Pure Global
NCT05628064

1C70 Feasibility Study

Prospective, Feasibility Study to Evaluate Performance, Patient Benefits, and Acceptance of a New 1C70 Energy Storage and Return Prosthetic Foot
Otto Bock Healthcare Products GmbH·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Amputation
Drug/Device/Intervention
1C70
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Otto Bock Healthcare Products GmbH
Location
Göttingen,Hannover,Heidelberg,Münster,Nürnberg,Traunstein, Germany
Timeline & enrollment
Phase
N/A
Start date
Nov 21, 2022
End date
Jun 30, 2023
Enrollment
20 participants
Primary outcome

Extent of meeting amputees prosthetic foot needs: 1C70 vs everyday foot,Extent of meeting amputees prosthetic foot needs: 1C70 vs comparator foot,Change in patient-perceived mobility (PLUS-M) compared to baseline,Change in patient-perceived mobility (PLUS-M) compared to the comparator foot,Highest pain reported: 1C70 vs everyday foot,Highest pain reported: 1C70 vs comparator foot

Summary

The objective of this study is to characterize the extend of 1C70 meeting the amputees needs
 in comparison with their everyday and a comparator foot, in regards of daily activities,
 mobility and balance, as well as quality of life and pain.

ICD-10 classifications
Amputation of limb(s)Traumatic amputation of both feetTraumatic amputation of upper and lower limbs, any combination [any level]Traumatic amputations involving other combinations of body regionsTraumatic amputation of lower leg
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05628064
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05628064 through Pure Global AI's free database. This phase not specified trial is sponsored by Otto Bock Healthcare Products GmbH and is currently Not yet recruiting. The study focuses on Amputation. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.